TREATMENT OF HALF SIDED HEADACHE (MIGRANE) USING VIDANGADI ARKA AS NASAL DROPS IN NASYA KARMA

OPEN LABELLED CLINICAL CONTROL STUDY TO EVALUATE THE EFFICACY OF VIDANGADI ARKA NASYA IN THE MANAGEMENT OF ARDHAVABHEDAKA

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021262

Enrollment

Registered

2019-09-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache

Interventions

Intervention1: Vidangadi Arka: Vidangadi Arka used in the form of nasal drops in nasya karma Route of administration is nasal Route Dose 6 drops each nostril for 7 days Control Intervention1: not app

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having the classical clinical features of Ardhavabhedaka and migraine without aura. 2. Patients aged between 16-60 years of either sex. 3. Patients fit for nasya karma.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients having a history of head trauma and other type of headaches. 2. Patients having any inflammatory diseases in nose, PNS, eyes and ears. 3. Patients with other systemic disorders like hypertension, diabetes mellitus etc.

Design outcomes

Primary

Measure	Time frame
Significance Reduce in headache ,nausea ,vomiting ,Timepoint: After 7 days of treatment	—

Secondary

Measure	Time frame
complete absence and reduce in the headache and associated complaintsTimepoint: After 14 days	—

Countries

India

Contacts

Public ContactDrVeerayya R Hiremath

SHRI JAGADGURU GAVISIDDESHWARA AYURVEDIC MEDICAL COLLEGE AND HOSPITAL

drmurarisreenivasulu@gmail.com9032653465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026